4 patents
Utility
Methods and Compositions for Treating Subjects with Metabolic Disorders and Coronavirus Infections
6 Jul 23
Provided herein are thiazolidinedione analogues that are useful for treating metabolic disorders and/or coronavirus infections.
Gerard R. COLCA
Filed: 14 Oct 22
Utility
Thiazolidinedione Analogs for the Treatment of Nafld and Metabolic Diseases
19 Jan 23
Provided herein are thiazolidinedione analogues that are useful for treating non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), diabetes, and other metabolic inflammation-mediated disease and disorders.
Gerard R. COLCA, Howard C. DITTRICH, Brian K. FARMER, Gad COTTER, Beth Anne COTTER-DAVISON
Filed: 6 May 22
Utility
zabn5 9hxuc5u9jrkqt4sefn9hcb98
3 Feb 22
Provided herein are thiazolidinedione analogues that are useful for treating non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), diabetes, and other metabolic inflammation-mediated disease and disorders.
Gerard R. COLCA, Howard C. DITTRICH, Brian K. FARMER
Filed: 9 Jul 21
Utility
emvmtir08nug1l63raicgrjjuyfrbztm
25 Nov 21
Provided herein are thiazolidinedione analogues that are useful for treating non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), diabetes, and other metabolic inflammation-mediated disease and disorders.
Gerard R. COLCA
Filed: 3 May 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first